USG Partners

The achievement of our ambitious goals and implementation of the GHI principles are only possible through the consolidated and coordinated efforts of all the USG agencies working in partnership with the global TB community to combat TB worldwide. The United States Agency for International Development (USAID) is the lead USG agency in international TB control.

USAID works closely with the Office of the Global AIDS Coordinator (OGAC) at the Department of State; OGAC is the lead for the USG response to TB-HIV co-infection as part of PEPFAR.

A key partner in the USAID response and the PEPFAR program is the U.S. Centers for Disease Control and Prevention (CDC), an agency under Department of Health and Human Services (HHS). CDC leads domestic USG TB control efforts and provides critical technical support to international partners on epidemiology and surveillance (including drug-resistant TB), laboratory strengthening, and clinical/operational research that evaluates promising diagnostic and treatment strategies, and informs the efficient use of new approaches to TB care. CDC also funds the TB Clinical Trials Consortium and the TB Epidemiologic Studies Consortium to fill current TB knowledge gaps in TB diagnostics, TB treatment regimens, case detection, and monitoring.

Finally, the National Institutes of Health (NIH) leads the way in improving the biomedical understanding of TB and conducts basic, applied, and clinical research on both drug-sensitive and drug-resistant TB and is heavily involved in the discovery and early development of new drugs, vaccines and diagnostics. All of these agencies are active members of the Stop TB Partnership.